Demand for compliant, patient safe packs will help drive the global blister packaging market to a total value of $32.5bn by 2015, according to new research.
Life sciences firm DSM has landed the contract to manufacture supplies of NicOx’ much vaunted anti-inflammatory agent naproxcinod and looks good for the long term deal.
GlaxoSmithKline has opted not to sign an exclusive development
agreement with UK sexual health specialist Futura Health for its
transdermal pain relief product, TPR100.
The first ever non-steroidal anti-inflammatory drug (NSAID) to be
delivered via the nose has been developed, and its makers are
heralding it as "an important breakthrough in treating
pain".
Granules India and Biocause have signed an agreement to create a 50
: 50 joint venture entity to manufacture and sell pharmaceutical
APIs (Active Pharmaceutical Ingredients), starting with Ibuprofen.
Celtic Pharma has announced the acquisition of a stake in IDEA - a
biopharma company, which is developing targeted therapeutics based
on novel, Transfersome carriers that can increase drug potency and
diminish harmful side effects.
Applied Pharma Research, a Swiss R&D firm specialising in drug
delivery, has granted an exclusive license to US drugmaker ProEthic
Pharmaceuticals to develop and market two fast-acting formulations
of the painkiller diclofenac...
Antares Pharma has announced that it has completed formulation and
preclinical activities for its first fast melt oral tablet
incorporating a nonsteroidal anti-inflammatory drug (NSAID) using
its Easy Tec fast melt technology.
US officials attempted to restore the reputation of the
pharmaceutical industry by announcing plans to introduce an
independent board, which aims to monitor the safety of drugs on the
market.
A new report suggests that recent safety concerns over certain
blockbuster drugs, notably Merck's Vioxx (rofecoxib) and Pfizer's
Celebrex (celecoxib), has placed the COX-2 inhibitor drug class
under intense scrutiny and...
Non-steroidal anti-inflammatory drugs (NSAIDs) are more likely to
cause gastrointestinal side effects than has been thought,
according to the results of a small study, reports Wai Lang
Chu.
The ongoing controversy concerning certain drugs and a link to
heart trouble gained further momentum after the Food and Drug
Administration (FDA) issued a warning for the pain reliever
naproxen after researchers found an increased...
A new study suggests that there are important differences between
Merck & Co's Vioxx (rofecoxib) and other COX-2 inhibitors and
that this may account for variations in cardiovascular safety
within this drug class, writes...
Drug company Merck, has presented data this week showing its latest
arthrirtis drug, Arcoxia, a treatment in the same class as its
recently withdrawn Vioxx, displays no significant difference in the
number of serious side effects...
A best-selling drug used by millions worldwide to treat arthritis
has been withdrawn from the market after comprehensive clinical
data confirmed long-established concerns that the treatment could
increase the risk of heart attacks...
A small US company has developed an encapsulation technology for
pharmaceuticals that promises to overcome a major healthcare
problem - deaths and illness caused by aspirin and other
non-steroidal anti-inflammatory drugs (NSAIDs).
